To investigate the underlying mechanism of GHR silence sensitizing HCC cells to sorafenib, this study detected molecules of ERK1/2, and PI3K/AKT signaling pathways in HepG2 and Huh7 cells after si GHR and drug treatment by using western blotting assay. Here, AKT1 is linked to hepatocellular carcinoma.